全文获取类型
收费全文 | 82049篇 |
免费 | 5351篇 |
国内免费 | 187篇 |
专业分类
耳鼻咽喉 | 802篇 |
儿科学 | 3163篇 |
妇产科学 | 2186篇 |
基础医学 | 10016篇 |
口腔科学 | 931篇 |
临床医学 | 12674篇 |
内科学 | 14203篇 |
皮肤病学 | 1040篇 |
神经病学 | 7632篇 |
特种医学 | 1649篇 |
外科学 | 7134篇 |
综合类 | 924篇 |
一般理论 | 193篇 |
预防医学 | 11583篇 |
眼科学 | 1552篇 |
药学 | 5201篇 |
中国医学 | 76篇 |
肿瘤学 | 6628篇 |
出版年
2023年 | 415篇 |
2022年 | 598篇 |
2021年 | 1394篇 |
2020年 | 960篇 |
2019年 | 1488篇 |
2018年 | 1717篇 |
2017年 | 1371篇 |
2016年 | 1530篇 |
2015年 | 1774篇 |
2014年 | 2442篇 |
2013年 | 3958篇 |
2012年 | 5591篇 |
2011年 | 5959篇 |
2010年 | 3322篇 |
2009年 | 2942篇 |
2008年 | 5381篇 |
2007年 | 5870篇 |
2006年 | 5663篇 |
2005年 | 5749篇 |
2004年 | 5498篇 |
2003年 | 5158篇 |
2002年 | 4817篇 |
2001年 | 895篇 |
2000年 | 742篇 |
1999年 | 852篇 |
1998年 | 1027篇 |
1997年 | 889篇 |
1996年 | 723篇 |
1995年 | 722篇 |
1994年 | 668篇 |
1993年 | 540篇 |
1992年 | 512篇 |
1991年 | 471篇 |
1990年 | 420篇 |
1989年 | 410篇 |
1988年 | 426篇 |
1987年 | 377篇 |
1986年 | 340篇 |
1985年 | 364篇 |
1984年 | 377篇 |
1983年 | 359篇 |
1982年 | 383篇 |
1981年 | 375篇 |
1980年 | 295篇 |
1979年 | 249篇 |
1978年 | 236篇 |
1977年 | 153篇 |
1976年 | 151篇 |
1974年 | 157篇 |
1973年 | 135篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
David C. Cone MD Susan M. Nedza MD MBA James J. Augustine MD Steven J. Davidson MD MBA 《Academic emergency medicine》2002,9(11):1085-1090
This paper reports the proceedings of the discussion panel assigned to look at clinical aspects of quality in emergency medicine. One of the seven stated objectives of the Academic Emergency Medicine consensus conference on quality in emergency medicine was to educate emergency physicians regarding quality measures and quality improvement as essential aspects of the practice of emergency medicine. Another topic of interest was a discussion of the value of information technology in facilitating quality care in the clinical practice of emergency medicine. It is important to note that this is not intended to be a comprehensive review of this extensive topic, but instead is designed to report the discussion that occurred at this session of the consensus conference. 相似文献
44.
The aim of the study was to determine the effect of exogenous melatonin treatment on circulating prolactin levels in red deer. Melatonin was administered from 12 June 1984 (day 1) to lactating and non-lactating hinds in the feed daily at 1600 h, and to non-lactating hinds by a subcutaneous implant. Average concentrations (ng/ml) of prolactin in plasma taken serially over 15-h periods were significantly higher for untreated hinds than for melatonin-treated animals on day 15 whether lactating (66-133 v. 23-28, P less than 0.05) or non-lactating (28-174 v. 8-13, P less than 0.01), remained higher on day 36 (lactating: 41-152 v. 15-21, P less than 0.05; non-lactating: 21-50 v. 1-7, P less than 0.001) but had decreased to similar levels on day 72 (lactating: 5-24 v. 7-17; non-lactating: 2-9 v. 0-4). The advanced reduction in plasma prolactin for all melatonin-treated hinds was associated with an advanced onset of seasonal breeding activity. 相似文献
45.
46.
47.
Pressure ulcers are a high-risk, high-volume, and high-cost problem for persons with disabilities. This article describes four tools published in the literature and reports the validity, reliability, strengths, and limitations of each. These tools include the Pressure Ulcer Scale for Healing (PUSH), the Pressure Sore Status Tool (PSST), the Sussman Wound Healing Tool (SWHT), and the Sessing Scale. Rehabilitation nurses should use a consistent framework with accurate quantification to assess, document, and monitor changes in pressure ulcers over time. Such a measurement tool must prove valid for the disabled population in which the tool is used. This will enable healthcare providers to communicate more effectively and evaluate the therapeutic plan of care. 相似文献
48.
Susan B Fowler Michael Moussouttas Barbara Mancini 《The Journal of neuroscience nursing》2005,37(4):220-223
Metabolic syndrome is associated with increased risk for cardiovascular and cerebrovascular disease. The World Health Organization and National Cholesterol Education Program Adult Treatment Panel III have identified physiologic abnormalities associated with metabolic syndrome, including impaired glucose metabolism, high blood pressure, elevated cholesterol levels, and abdominal obesity. It is estimated that 47 million Americans have metabolic syndrome. A variety of therapies may help reduce the incidence and risk, including diet, weight loss, physical exercise, glycemic control, and pharmacological treatments. Nursing care is focused on developing an individualized plan of care that includes family members and providing education, psychosocial support, close monitoring, and continued follow-up to ensure adherence and success in achieving patient outcomes. 相似文献
49.
50.
Leslee J. Shaw Romalisa Miranda-Peats Piotr Slomka John Friedman Sean W. Hayes Daniel S. Berman Gary V. Heller Marcin Dada William E. Boden Paul Casperson Robert A. O’Rourke Ronald Schwartz William S. Weintraub David J. Maron Spencer King Koon Teo Pamela Hartigan 《Journal of nuclear cardiology》2006,13(5):685-698
Background Stress gated myocardial perfusion single photon emission computed tomography (gSPECT) is increasingly used before and after
intercurrent therapeutic intervention and is the basis for ongoing evaluation in the Department of Veterans Affairs clinical
outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial.
Methods and Results The COURAGE trial is a North American multicenter randomized clinical trial that enrolled 2287 patients to aggressive medical
therapy vs percutaneous coronary intervention plus aggressive medical therapy. Three COURAGE nuclear substudies have been
designed. The goals of substudy 0 are to examine the diagnostic accuracy of the extent and severity of inducible ischemia
at baseline in COURAGE patients compared with patient symptoms and quantitative coronary angiography and to explore the relationship
between inducible ischemia and the benefit from revascularization when added to medical therapy. Substudy 1 will correlate
the extent and severity of provocative ischemia with the frequency, quality, and instability of recurrent symptoms in postcatheterization
patients. Substudy 2 (n _ 300) will examine the usefulness of sequential gSPECT monitoring 6 to 18 months after therapeutic
intervention. Together, these nuclear substudies will evaluate the role of gSPECT to determine the effectiveness of aggressive
risk-factor modifications, lifestyle interventions, and anti-ischemic medical therapies with or without revascularization
in reducing patients’ ischemic burdens.
Conclusions The unfolding of evidence on the application of gSPECT in trials such as COURAGE defines a new era for nuclear cardiology.
We hope the evidence that emerges from the COURAGE trial will further establish the role of nuclear imaging in the evidence-based
management of patients with stable coronary disease.
The COURAGE trial was supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research
and Development in collaboration with the Canadian Institutes of Health Research. Unrestricted research grants were obtained
from Merck & Co; Pfizer Pharmaceuticals; Bristol-Myers Squibb Medical Imaging; Astellas Pharma; Kos Pharmaceuticals; Data
Scope; Astra Zeneca Pharmaceuticals; Astra-Zeneca-Canada; Schering-Plough Coorporation, Ltd; Sanofi-Aventis, Inc; First Horizon;
and GE Healthcare. All industrial funding for this trial was directed through the Department of Veterans Affairs. Additional
funding for this substudy was provided by grants to the Department of Veterans Affairs and Canadian Institutes of Health Research
from Astellas Pharma and Bristol-Myers-Squibb Medical Imaging. 相似文献